Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Pharmacogenomics|December 23, 2006
Overview of the pharmacoeconomics of pharmacogeneticsThierry Dervieux, Mohan V Bala
Mutation Research|April 15, 2005
Pharmacogenetic testing: proofs of principle and pharmacoeconomic implicationsThierry Dervieux, Brian Meshkin, Bruce Neri
Lupus Science & Medicine|June 7, 2019
Platelet-bound C4d, low C3 and lupus anticoagulant associate with thrombosis in SLEMichelle A Petri, John Conklin, Tyler O'Malley, et al.
Annals of the Rheumatic Diseases|November 20, 2012
Methotrexate polyglutamation in relation to infliximab pharmacokinetics in rheumatoid arthritisThierry Dervieux, Michael E Weinblatt, Alan Kivitz, et al.
Lupus Science & Medicine|December 8, 2017
Cell-bound complement activation products in SLERosalind Ramsey-Goldman, Jian Li, Thierry Dervieux, et al.
Clinical and Experimental Rheumatology|March 8, 2013
Fibroblasts from methotrexate-sensitive mice accumulate methotrexate polyglutamates but those from methotrexate-resistant mice do notXin You, Adrienne Williams, Thierry Dervieux, et al.
Crohn'S & Colitis 360|June 29, 2026
The association between 6-thioguanine nucleotide levels, adalimumab exposure, immune response, and drug clearanceAndres Yarur, Jonathan C Lo, Bincy Abraham, et al.
Lupus Science & Medicine|February 13, 2016
Systemic lupus erythematosus and primary fibromyalgia can be distinguished by testing for cell-bound complement activation productsDaniel J Wallace, Stuart L Silverman, John Conklin, et al.
Pageof 6